Schwabe Stefan K.F. Insider Trades

Insider Trading History

Track insider trading activity for Schwabe Stefan K.F.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Executive Vice President & CMO
Holding Value $124k 2,772 shares
Last Trade
Dec 21, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.02M 46,347 shares
$22.10
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Executive Vice President & CMO
Holding Value $2.2M 49,119 shares
Last Trade
Dec 21, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.04M 46,347 shares
$22.42
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Executive Vice President & CMO
Holding Value $0 0 shares
Last Trade
Dec 21, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.04M 46,347 shares
$22.42
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Executive Vice President & CMO
Holding Value $2.52M 56,425 shares
Last Trade
Dec 14, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.16M 53,653 shares
$21.68
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Executive Vice President & CMO
Holding Value $2.07M 46,347 shares
Last Trade
Dec 14, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.16M 53,653 shares
$21.68
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Executive Vice President & CMO
Holding Value $287k 6,425 shares
Last Trade
Dec 14, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.17M 53,653 shares
$21.87
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Executive Vice President & CMO
Holding Value $2.24M 50,000 shares
Last Trade
Feb 21, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.2M 50,000 shares
$23.99
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Executive Vice President R&d
Holding Value $1.79M 40,000 shares
Last Trade
Feb 22, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.47M 40,000 shares
$36.75
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Executive VP R&d, CMO
Holding Value $2.77M 61,967 shares
Last Trade
Jun 18, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.25M 60,000 shares
$54.15
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Executive VP R&d, CMO
Holding Value $87.9k 1,967 shares
Last Trade
Jun 18, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.26M 60,000 shares
$54.39
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Executive VP R&d, CMO
Holding Value $0 0 shares
Last Trade
Jun 18, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.25M 60,000 shares
$54.15
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Executive Vice President R&d
Holding Value $1.34M 30,000 shares
Last Trade
Feb 14, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.18M 30,000 shares
$39.40
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Executive Vice President R&d
Holding Value $82.9k 1,855 shares
Last Trade
Sep 07, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.43M 95,000 shares
$46.59
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Executive Vice President R&d
Holding Value $4.33M 96,855 shares
Last Trade
Sep 07, 2017 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.54M 95,000 shares
$47.80
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Executive Vice President R&d
Holding Value $0 0 shares
Last Trade
Sep 07, 2017 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.54M 95,000 shares
$47.80
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Executive Vice President R&d
Holding Value $2.24M 50,000 shares
Last Trade
Feb 24, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.27M 50,000 shares
$25.30
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Executive Vice President R&d
Holding Value $2.24M 50,000 shares
Last Trade
Mar 01, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$649k 50,000 shares
$12.98
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Executive Vice President R&d
Holding Value $76k 1,700 shares
Last Trade
Jul 28, 2015 Sale (Open Market)Shares sold on the open market or in a private sale.
$49.8k 2,350 shares
$21.20
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Executive Vice President R&d
Holding Value $37.7k 844 shares
Last Trade
Jul 13, 2015 Sale (Open Market)Shares sold on the open market or in a private sale.
$37.5k 1,950 shares
$19.23
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Executive Vice President R&d
Holding Value $105k 2,350 shares
Last Trade
Jul 13, 2015 Sale (Open Market)Shares sold on the open market or in a private sale.
$37.5k 1,950 shares
$19.23
$44.70

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up